Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | Chief Human Resources Officer | September 01, 2020 | September 02, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date September 01, 2020 · Filed September 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,232 |
Reported balance
After 2020-09-01 transaction · row 1
1 source rowRow 1 · 2020-09-01 · Exercise / conversion · Acquired 764 · Balance 3,232 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.75 · Expires 2028-02-20 | Direct | 25,498 |
Reported balance
After 2020-09-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-09-01 · Exercise / conversion · Disposed 764 · Balance 25,498 F1: The option vests as to 25% of the shares on February 20, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests as to 25% of the shares on February 20, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Jamf Holding Corp.
Report date January 30, 2026 · Filed February 04, 2026
Section 16 reporting ended · disclosed 2026-02-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-01-30 transaction · row 1
1 source rowRow 1 · 2026-01-30 · Disposition to issuer · Disposed 257,473 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of October 28, 2025 (the "Merger Agreement"), by and among the Issuer, Jawbreaker Parent, Inc. ("Parent") and Jawbreaker Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of the Issuer's common stock, par value $0.001 per share ("Common Stock"), owned by the reporting person immediately prior to the Effective Time was automatically cancelled, extinguished and converted into the right to receive $13.05 per share in cash, without interest thereon (the "Per Share Price"). F2: The shares of Common Stock reported as disposed by the reporting person include 230,225 unvested restricted stock units ("Company RSUs") which, pursuant to the Merger Agreement, were, at or immediately prior to the Effective Time, cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (i) the Per Share Price and (ii) the total number of shares of Common Stock subject to such Company RSUs as of immediately prior to the Effective Time (the "Converted Cash Awards"). The Converted Cash Awards will, subject to the reporting person's continued service through the applicable vesting dates, vest and be payable at the time when the Company RSUs for which the Converted Cash Awards were exchanged would have vested pursuant to the terms thereof. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of October 28, 2025 (the "Merger Agreement"), by and among the Issuer, Jawbreaker Parent, Inc. ("Parent") and Jawbreaker Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of the Issuer's common stock, par value $0.001 per share ("Common Stock"), owned by the reporting person immediately prior to the Effective Time was automatically cancelled, extinguished and converted into the right to receive $13.05 per share in cash, without interest thereon (the "Per Share Price").
F2: The shares of Common Stock reported as disposed by the reporting person include 230,225 unvested restricted stock units ("Company RSUs") which, pursuant to the Merger Agreement, were, at or immediately prior to the Effective Time, cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (i) the Per Share Price and (ii) the total number of shares of Common Stock subject to such Company RSUs as of immediately prior to the Effective Time (the "Converted Cash Awards"). The Converted Cash Awards will, subject to the reporting person's continued service through the applicable vesting dates, vest and be payable at the time when the Company RSUs for which the Converted Cash Awards were exchanged would have vested pursuant to the terms thereof.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 30, 2026 Filed Feb 4, 2026 00:35 UTC | Jamf Holding Corp. JAMF · Entity 67879 | Disposition to issuerCommon Stock | 257,473 | $13.05 | $3,360,022.65 |
DisclosureSEC source: 0001104659-26-009897 · tm264920-11_4seq1.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger, dated as of October 28, 2025 (the "Merger Agreement"), by and among the Issuer, Jawbreaker Parent, Inc. ("Parent") and Jawbreaker Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of the Issuer's common stock, par value $0.001 per share ("Common Stock"), owned by the reporting person immediately prior to the Effective Time was automatically cancelled, extinguished and converted into the right to receive $13.05 per share in cash, without interest thereon (the "Per Share Price"). F2 · kind: The shares of Common Stock reported as disposed by the reporting person include 230,225 unvested restricted stock units ("Company RSUs") which, pursuant to the Merger Agreement, were, at or immediately prior to the Effective Time, cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (i) the Per Share Price and (ii) the total number of shares of Common Stock subject to such Company RSUs as of immediately prior to the Effective Time (the "Converted Cash Awards"). The Converted Cash Awards will, subject to the reporting person's continued service through the applicable vesting dates, vest and be payable at the time when the Company RSUs for which the Converted Cash Awards were exchanged would have vested pursuant to the terms thereof. Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 22:27 UTC | Jamf Holding Corp. JAMF · Entity 67879 | SaleCommon Stock | 15,393 | $9.37 | $144,255.50 |
DisclosureSEC source: 0001562180-25-004954 · primarydocument.xml · nonDerivative · entry 2 Bucaria Michelle · CIK 0001732468 · CPO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 257,473 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2025 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.295 to $9.490, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 22:27 UTC | Jamf Holding Corp. JAMF · Entity 67879 | SaleCommon Stock | 5,712 | $9.57 | $54,651.27 |
DisclosureSEC source: 0001562180-25-004954 · primarydocument.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · CPO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 272,866 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2025 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.43 to $9.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 22:13 UTC | Jamf Holding Corp. JAMF · Entity 67879 | SaleCommon Stock | 12,656 | $13.55 | $171,474.88 |
DisclosureSEC source: 0001562180-25-002673 · primarydocument.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,578 F1 · kind: The sale was made pursuant to an automatic sale-to-cover transaction with respect to required tax withholding obligations. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.4653 to $13.6200, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 22:36 UTC | Jamf Holding Corp. JAMF · Entity 67879 | GrantCommon Stock | 113,895 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-002560 · primarydocument.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,234 Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 22:02 UTC | Jamf Holding Corp. JAMF · Entity 67879 | SaleCommon Stock | 12,782 | $15.25 | $194,944.67 |
DisclosureSEC source: 0001562180-24-005204 · primarydocument.xml · nonDerivative · entry 2 Bucaria Michelle · CIK 0001732468 · CPO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 177,339 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.18 to $15.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 22:02 UTC | Jamf Holding Corp. JAMF · Entity 67879 | SaleCommon Stock | 24,282 | $15.45 | $375,237.03 |
DisclosureSEC source: 0001562180-24-005204 · primarydocument.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · CPO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 190,121 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.30 to $15.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| March 20, 2024 Filed Mar 21, 2024 21:38 UTC | Jamf Holding Corp. JAMF · Entity 67879 | SaleCommon Stock | 8,094 | $17.92 | $145,045.29 |
DisclosureSEC source: 0001562180-24-002912 · primarydocument.xml · nonDerivative · entry 2 Bucaria Michelle · CIK 0001732468 · CPO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,403 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.72 to $18.09, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 21:38 UTC | Jamf Holding Corp. JAMF · Entity 67879 | SaleCommon Stock | 7,583 | $17.86 | $135,431.62 |
DisclosureSEC source: 0001562180-24-002912 · primarydocument.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · CPO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 222,497 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.67 to $17.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:07 UTC | Jamf Holding Corp. JAMF · Entity 67879 | GrantCommon Stock | 84,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-002827 · primarydocument.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,080 Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 22:00 UTC | Jamf Holding Corp. JAMF · Entity 67879 | SaleCommon Stock | 8,396 | $19.29 | $161,989.07 |
DisclosureSEC source: 0001562180-23-005413 · primarydocument.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · CPO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,573 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.21 to $19.44, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:02 UTC | Jamf Holding Corp. JAMF · Entity 67879 | GrantCommon Stock | 75,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002901 · primarydocument.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · CPO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,969 Read SEC document |
| July 11, 2022 Filed Jul 13, 2022 20:31 UTC | Jamf Holding Corp. JAMF · Entity 67879 | Tax withholdingCommon Stock | 3,239 | $27.11 | $87,800.54 |
DisclosureSEC source: 0001562180-22-005660 · primarydocument.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · CPO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,857 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.92 to $27.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| June 15, 2022 Filed Jul 5, 2022 21:59 UTC | Jamf Holding Corp. JAMF · Entity 67879 | GrantCommon Stock | 82,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005527 · primarydocument.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · CPO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,096 Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 764 | $0.00 Strike: $37.75 | $0.00 |
DisclosureSEC source: 0001179110-20-009486 · edgar.xml · derivative · entry 2 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,498 Underlying: Common Stock · 764 shares Expires 2028-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vests as to 25% of the shares on February 20, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 764 | $37.75 | $28,841.00 |
DisclosureSEC source: 0001179110-20-009486 · edgar.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 90 | $166.79 | $15,011.10 |
DisclosureSEC source: 0001179110-20-007010 · edgar.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,468 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan amendment that was adopted by the reporting person on May 4, 2020. Read SEC document |
| April 16, 2020 Filed Apr 20, 2020 20:38 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,256 | $0.00 Strike: $37.75 | $0.00 |
DisclosureSEC source: 0001179110-20-004984 · edgar.xml · derivative · entry 3 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,262 Underlying: Common Stock · 1,256 shares Expires 2028-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 20, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| April 16, 2020 Filed Apr 20, 2020 20:38 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,295 | $165.00 | $873,675.00 |
DisclosureSEC source: 0001179110-20-004984 · edgar.xml · nonDerivative · entry 2 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,468 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 7, 2020. Read SEC document |
| April 16, 2020 Filed Apr 20, 2020 20:38 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,256 | $37.75 | $47,414.00 |
DisclosureSEC source: 0001179110-20-004984 · edgar.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003223 · edgar.xml · derivative · entry 6 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,454 Underlying: Common Stock · 1,727 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 4, 2019, the reporting person was granted 5,181 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On March 4, 2019, the reporting person was granted 5,181 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 2,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003223 · edgar.xml · derivative · entry 5 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,490 Underlying: Common Stock · 2,245 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On February 26, 2020, the reporting person earned 6,735 performance stock units, vesting in three annual installments beginning on March 4, 2020. F4 · derivative.expiration_date: On February 26, 2020, the reporting person earned 6,735 performance stock units, vesting in three annual installments beginning on March 4, 2020. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 576 | $132.73 | $76,452.48 |
DisclosureSEC source: 0001179110-20-003223 · edgar.xml · nonDerivative · entry 4 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,507 F3 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,727 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-003223 · edgar.xml · nonDerivative · entry 3 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,083 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 750 | $132.73 | $99,547.50 |
DisclosureSEC source: 0001179110-20-003223 · edgar.xml · nonDerivative · entry 2 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,356 F3 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,245 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-003223 · edgar.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 3,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003064 · edgar.xml · derivative · entry 1 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,414 Underlying: Common Stock · 3,414 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 2, 2021. F2 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 2, 2021. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:29 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 6,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002582 · edgar.xml · derivative · entry 1 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,735 Underlying: Common Stock · 6,735 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F2 · shares: Performance award amount determined based on metrics in respect of the issuer's 2019 financial results. F3 · derivative.exercise_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. F3 · derivative.expiration_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002209 · edgar.xml · derivative · entry 3 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,987 Underlying: Common Stock · 1,986 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On February 20, 2018, the reporting person was granted 5,960 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On February 20, 2018, the reporting person was granted 5,960 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 774 | $112.89 | $87,376.86 |
DisclosureSEC source: 0001179110-20-002209 · edgar.xml · nonDerivative · entry 2 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,861 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,986 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-002209 · edgar.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,188 | $60.00 | $71,280.00 |
DisclosureSEC source: 0001179110-19-003916 · edgar.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,649 Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,649 | $0.00 Strike: $37.75 | $0.00 |
DisclosureSEC source: 0001179110-19-003733 · edgar.xml · derivative · entry 5 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,518 Underlying: Common Stock · 2,649 shares Expires 2028-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 25% of the shares on February 20, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,649 | $37.75 | $99,999.75 |
DisclosureSEC source: 0001179110-19-003733 · edgar.xml · nonDerivative · entry 3 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003733 · edgar.xml · derivative · entry 4 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,973 Underlying: Common Stock · 1,989 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On February 20, 2018, the reporting person was granted 5,960 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On February 20, 2018, the reporting person was granted 5,960 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 799 | $58.51 | $46,749.49 |
DisclosureSEC source: 0001179110-19-003733 · edgar.xml · nonDerivative · entry 2 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,188 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,987 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003733 · edgar.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:19 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 5,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003466 · edgar.xml · derivative · entry 1 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,181 Underlying: Common Stock · 5,181 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. F2 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.